The Louisiana House voted 97-2 yesterday to pass and send to the Senate legislation to stop drug manufacturer interference with 340B contract pharmacy arrangements. It also would prohibit pharmacy benefit manager and payor practices that lower reimbursement for 340B-purchased drugs.
HB 548 was referred to the Senate Health and Welfare Committee this morning. The House Health and Welfare Committee voted 14-0 on April 20 to pass it with just one amendment. That change deleted language that would have let 340B covered entities sue on their own behalf to get relief for alleged violations of the bill’s contract pharmacy provisions.
The Louisiana House voted 97-2 yesterday to pass and send to the Senate legislation to stop drug manufacturer interference with 340B contract pharmacy arrangements. It also would prohibit pharmacy benefit manager and payor practices that lower reimbursement for 340B-purchased drugs. […]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.